1-9 of 9
Li Weng
Close
Sort by
Journal Articles

Assessment of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia Patients Using Next-Generation Sequencing Method

John K. Choi, MD, Sima Jeha, MD, Li Weng, Victoria Carlton, Malek Faham, Ching-Hon Pui, MD
Journal: Blood
Blood (2014) 124 (21): 5343.
https://doi.org/10.1182/blood.V124.21.5343.5343
Published: 2014
Journal Articles

Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

Clinical Trials & Observations
Joaquin Martinez-Lopez, Juan J. Lahuerta, François Pepin, Marcos González, Santiago Barrio, Rosa Ayala, Noemí Puig, María A. Montalban, Bruno Paiva, Li Weng, Cristina Jiménez, María Sopena, Martin Moorhead, Teresa Cedena, Immaculada Rapado, María Victoria Mateos, Laura Rosiñol, Albert Oriol, María J. Blanchard, Rafael Martínez, Joan Bladé, Jesús San Miguel, Malek Faham, Ramón García-Sanz
Journal: Blood
Blood (2014) 123 (20): 3073–3079.
https://doi.org/10.1182/blood-2014-01-550020
Published: 2014
Journal Articles

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Greg Malnassy, MS, Susan Geyer, PhD, Noreen Fulton, B.S., Greg Koval, B.S., Donna Niedzwiecki, PhD, Victoria Carlton, PhD, Li Weng, PhD, Lawrence D. Kaplan, MD, Guido Marcucci, MD, Lloyd E Damon, MD, Richard A. Larson, MD, Richard M. Stone, MD, Bruce D. Cheson, M.D., Malek Faham, MD, PhD, Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 2547.
https://doi.org/10.1182/blood.V122.21.2547.2547
Published: 2013
Journal Articles

Use Of Rearranged Immune Receptor Sequencing To Measure Minimal Residual Disease (MRD) In Bone Marrow, Cerebrospinal Fluid and Testes In Relapsed Childhood Acute Lymphoblastic Leukemia

Norman J. Lacayo, MD, Li Weng, PhD, Charles Gawad, MD, Malek Faham, MD, PhD, Gary V Dahl, MD
Journal: Blood
Blood (2013) 122 (21): 4984.
https://doi.org/10.1182/blood.V122.21.4984.4984
Published: 2013
Journal Articles

Prognostic Value Of Deep Sequencing Approach For Minimal Residual Disease (MRD) Detection In Multiple Myeloma Patients

Joaquin Martinez-Lopez, MD, PhD, Juan José Laheurta, Francois Pepin, Marcos González, MD, Santiago Barrio, PhD, Rosa M. Ayala, MD, PhD, Noemí Puig, Maria Angeles Montalban, Bruno Paiva, Li Weng, PhD, Cristina Jimenez, Maria Sopena, Teresa Cedena, Inmaculada Rapado, Maria Victoria Mateo, Laura Rosiñol, MD, Albert Oriol, MD, María Jesús Blanchard, Rafael Martinez, MD, Joan Blade, MD, Jesus F San Miguel, Malek Faham, MD, PhD, Ramon Garcia-Sanz
Journal: Blood
Blood (2013) 122 (21): 1848.
https://doi.org/10.1182/blood.V122.21.1848.1848
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone

Sham Mailankody, MD, Neha Korde, MD, Malek Faham, MD, PhD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, Li Weng, PhD, Martin Moorhead, PhD, Rene Costello, Yong Zhang, PhD, Adriana Zingone, MD, PhD, Debbie Burton, Peter Wu, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Roger Kurlander, MD, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, M.D., Mark Roschewski, MD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1902.
https://doi.org/10.1182/blood.V122.21.1902.1902
Published: 2013
Journal Articles

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients

Nina Wagner-Johnston, MD, Nancy L. Bartlett, MD, Kenneth R. Carson, MD, Mary Anderson, Li Weng, PhD, Mark Klinger, PhD, Malek Faham, MD, PhD, Richard F. Ambinder
Journal: Blood
Blood (2013) 122 (21): 1785.
https://doi.org/10.1182/blood.V122.21.1785.1785
Published: 2013
Journal Articles

Rapid Mobilization Of CD34+ Progenitor Cells With TG0054-03, a novel CXC Chemokine Receptor 4 (CXCR4) Antagonoist

Michael W. Schuster, MD, Nabil Hagog, Ph.D., Bita Jalilizeinali, DNP, Sharon Funkhauser, RN, Mary Sophy Yohannan, MBBS, Jennifer Sadler, RN, Sylvia Wood, DNP, Stacy Carey, Karen Kelleher, Chen-En Tsai, M.D., Ph.D., Ming-Chu Hsu, Ph.D., Li-Weng Chang, Zora Hsu
Journal: Blood
Blood (2013) 122 (21): 905.
https://doi.org/10.1182/blood.V122.21.905.905
Published: 2013
Journal Articles

Clonosight: A Standardized Clinical Assay for Measurement of Minimal Residual Disease in Leukemias and Lymphomas

Thomas D. Willis, PhD, Tom Asbury, PhD, Victoria Carlton, PhD, Lei Fang, PhD, Mark Klinger, PhD, Martin Moorhead, PhD, Kaliprasad Pothuraju, MS, Li Weng, PhD, Jianbiao Zheng, PhD, Malek Faham, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1434.
https://doi.org/10.1182/blood.V120.21.1434.1434
Published: 2012